↓ Skip to main content

Cochrane Database of Systematic Reviews

Sustained‐Release Naltrexone For Opioid Dependence

Overview of attention for article published in Cochrane database of systematic reviews, April 2008
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
40 news outlets
blogs
1 blog
policy
1 policy source
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
97 Dimensions

Readers on

mendeley
200 Mendeley
Title
Sustained‐Release Naltrexone For Opioid Dependence
Published in
Cochrane database of systematic reviews, April 2008
DOI 10.1002/14651858.cd006140.pub2
Pubmed ID
Authors

Philipp Lobmaier, Hege Kornor, Nikolaj Kunoe, Arild Bjørndal

Abstract

Naltrexone is an opioid antagonist which effectively blocks heroin effects. Since opioid dependence treatment with naltrexone tablets suffers from high dropout rates, several depot injections and implants are under investigation. Sustained-release formulations are claimed to be effective, but a systematic review of the literature is lacking.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 200 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 2%
United Kingdom 1 <1%
France 1 <1%
Unknown 195 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 34 17%
Researcher 29 14%
Student > Ph. D. Student 21 11%
Student > Bachelor 20 10%
Other 12 6%
Other 37 19%
Unknown 47 24%
Readers by discipline Count As %
Medicine and Dentistry 70 35%
Psychology 17 9%
Social Sciences 11 6%
Nursing and Health Professions 10 5%
Agricultural and Biological Sciences 10 5%
Other 31 16%
Unknown 51 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 312. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 November 2022.
All research outputs
#112,907
of 25,962,638 outputs
Outputs from Cochrane database of systematic reviews
#207
of 13,169 outputs
Outputs of similar age
#151
of 94,473 outputs
Outputs of similar age from Cochrane database of systematic reviews
#1
of 55 outputs
Altmetric has tracked 25,962,638 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,169 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.3. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 94,473 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.